BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

979 related articles for article (PubMed ID: 27434221)

  • 1. Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.
    Svane MS; Jørgensen NB; Bojsen-Møller KN; Dirksen C; Nielsen S; Kristiansen VB; Toräng S; Wewer Albrechtsen NJ; Rehfeld JF; Hartmann B; Madsbad S; Holst JJ
    Int J Obes (Lond); 2016 Nov; 40(11):1699-1706. PubMed ID: 27434221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass.
    le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; Ghatei MA; Bloom SR; Olbers T
    Ann Surg; 2007 Nov; 246(5):780-5. PubMed ID: 17968169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 and PYY
    Dischinger U; Corteville C; Otto C; Fassnacht M; Seyfried F; Hankir MK
    Surg Obes Relat Dis; 2019 Sep; 15(9):1483-1492. PubMed ID: 31548004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass.
    Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW
    Int J Obes (Lond); 2012 Mar; 36(3):379-84. PubMed ID: 21694700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Postoperative Endogenous GLP-1 Levels Mediate Effects of Roux-en-Y Gastric Bypass on Neural Responsivity to Food Cues.
    Ten Kulve JS; Veltman DJ; Gerdes VEA; van Bloemendaal L; Barkhof F; Deacon CF; Holst JJ; Drent ML; Diamant M; IJzerman RG
    Diabetes Care; 2017 Nov; 40(11):1522-1529. PubMed ID: 29025878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
    Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J
    J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
    Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
    Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction.
    Evans S; Pamuklar Z; Rosko J; Mahaney P; Jiang N; Park C; Torquati A
    Surg Endosc; 2012 Apr; 26(4):1086-94. PubMed ID: 22044971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass.
    de Hollanda A; Jiménez A; Corcelles R; Lacy AM; Patrascioiu I; Vidal J
    Surg Obes Relat Dis; 2014; 10(5):814-9. PubMed ID: 24969090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of meal size on the release of GLP-1 and PYY after Roux-en-Y gastric bypass surgery in obese subjects with or without type 2 diabetes.
    Yan W; Polidori D; Yieh L; Di J; Wu X; Moreno V; Li L; Briscoe CP; Shankley N; Dohm GL; Pories WJ
    Obes Surg; 2014 Nov; 24(11):1969-74. PubMed ID: 24972682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
    Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
    Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass.
    de Hollanda A; Casals G; Delgado S; Jiménez A; Viaplana J; Lacy AM; Vidal J
    J Clin Endocrinol Metab; 2015 Dec; 100(12):4677-84. PubMed ID: 26505823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake.
    Bojsen-Møller KN; Svane MS; Martinussen C; Dirksen C; Jørgensen NB; Jensen JB; Jensen CZ; Torekov SS; Kristiansen VB; Rehfeld JF; Bork-Jensen J; Grarup N; Hansen T; Hartmann B; Holst JJ; Madsbad S
    Int J Obes (Lond); 2023 Nov; 47(11):1143-1151. PubMed ID: 37653071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appetite, Glycemia, and Entero-Insular Hormone Responses Differ Between Oral, Gastric-Remnant, and Duodenal Administration of a Mixed-Meal Test After Roux-en-Y Gastric Bypass.
    Gero D; Steinert RE; Hosa H; Cummings DE; Bueter M
    Diabetes Care; 2018 Jun; 41(6):1295-1298. PubMed ID: 29636353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass: a randomized clinical trial.
    Chronaiou A; Tsoli M; Kehagias I; Leotsinidis M; Kalfarentzos F; Alexandrides TK
    Obes Surg; 2012 Nov; 22(11):1761-70. PubMed ID: 22911148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dipeptidyl peptidase IV inhibition on glycemic, gut hormone, triglyceride, energy expenditure, and energy intake responses to fat in healthy males.
    Heruc GA; Horowitz M; Deacon CF; Feinle-Bisset C; Rayner CK; Luscombe-Marsh N; Little TJ
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E830-7. PubMed ID: 25231186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.